SCHEMBL13570515

SCHEMBL13570515

O=C(NC(=O)[C@H](O)c1ccccc1)C1CCCN1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
CTSC P53634 2/20 0.49
TSHR P16473 2/20 0.47
CYP2C9 P11712 1/20 0.47
HTR2C P28335 2/20 0.44
HTR2B P41595 2/20 0.44
SLC6A3 Q01959 5/20 0.42
SLC6A2 P23975 3/20 0.42
SLC6A4 P31645 2/20 0.42
DHFR P00374 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GPR88 Q9GZN0 1/20 0.41
ITGB3 P05106 1/20 0.40
ITGAV P06756 1/20 0.40
ITGA2B P08514 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980125 0.89 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570425 0.84 ITGB3 (0.52) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL2176484 0.83 CYP3A4 (0.55) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570392 0.83 CYP3A4 (0.49) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570579 0.82 CYP3A4 (0.51) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL13570423 0.80 HDAC2 (0.43) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL24056571 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL7305357 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL24057819 0.79 LMNA (0.60) CYP3A4CYP2D6CYP1A2CYP2C19CTSC
SCHEMBL12333752 0.78 CYP3A4 (0.55) CYP3A4CYP2D6CYP1A2CYP2C19CTSC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP disclosed